NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that its CombiMatrix group has updated its Influenza-Detection System, which consists of the CombiMatrix Influenza A Microarray, ElectraSense™ reader, and sample-preparation kit. The system is the most-comprehensive commercially available Influenza A detection system available. The new version, v4.1, of the system’s content (the probes on the array and the sample preparation) takes into account the more than 2,000 new sequences that have been recently released by the Influenza Genome Sequencing Project.
